|
NMRAL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.82210000005045E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.61489999997533E-06 |
| Normal-vs-Stage2 |
3.291000E-01 |
| Normal-vs-Stage3 |
7.785800E-04 |
| Normal-vs-Stage4 |
1.87027999999367E-05 |
| Stage1-vs-Stage2 |
2.861900E-02 |
| Stage1-vs-Stage3 |
5.279200E-01 |
| Stage1-vs-Stage4 |
4.217400E-01 |
| Stage2-vs-Stage3 |
1.182960E-01 |
| Stage2-vs-Stage4 |
1.935780E-02 |
| Stage3-vs-Stage4 |
2.311400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.9564000000315E-06 |
| Normal-vs-AfricanAmerican |
1.173210E-04 |
| Normal-vs-Asian |
2.800700E-03 |
| Caucasian-vs-AfricanAmerican |
3.400000E-01 |
| Caucasian-vs-Asian |
6.568200E-01 |
| AfricanAmerican-vs-Asian |
1.914980E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.217600E-03 |
| Normal-vs-Female |
1.84439999995067E-06 |
| Male-vs-Female |
2.620000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.68379999999835E-05 |
| Normal-vs-Age(41-60Yrs) |
1.82655999999559E-05 |
| Normal-vs-Age(61-80Yrs) |
1.498160E-02 |
| Normal-vs-Age(81-100Yrs) |
4.544500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.249400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.443760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.948400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.568040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.704600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.484600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.151830E-01 |
| Classical-VS-Follicular |
5.57519999999645E-05 |
| Classical-VS-Other |
7.525000E-01 |
| Classical-VS-Normal |
6.36570000045467E-08 |
| Tall-VS-Follicular |
2.04769999999632E-05 |
| Tall-VS-Other |
2.422600E-01 |
| Tall-VS-Normal |
2.53319999976576E-07 |
| Follicular-VS-Other |
2.847800E-01 |
| Follicular-VS-Normal |
6.636800E-01 |
| Other-VS-Normal |
5.228300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.798200E-03 |
| Normal-vs-N1 |
7.389100E-04 |
| N0-vs-N1 |
1.212440E-01 |
|
|
